Contract Services Methods Development
WuXi Biologics And HanchorBio Inc. Sign Strategic Collaboration To Advance Next Generation Fusion Biologics
WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a globa...
January 27, 2026 | News
Blau Farmacêutica Achieves End To End Development Of Pembrolizumab Biosimilar In Brazil
Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market (B3) and a regional leader in hospital pharmaceuticals w...
January 27, 2026 | News
Samsung Biologics Strengthens Long Term Growth Platform With Solid 2025 Financial Performance
Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW 4,557 billion Maintained momentum through consistent ...
January 22, 2026 | Company results
Dr Chris Chen Positions WuXi Biologics As The Defining Force Shaping The Future Of Global CRDMO Innovation
Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects ...
January 19, 2026 | News
Oricell Raises 70M$ In Series C1 To Advance First In Class CAR T Therapy For Liver Cancer
Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced the closing of a $70M Ser...
January 14, 2026 | News
WuXi Biologics Secures UK MHRA GMP Clearance For Wuxi Ophthalmic Manufacturing Sites
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing ...
January 14, 2026 | News
Esco Aster Provides CMC Manufacturing Support For Shine On Biomedical HLA G Targeted Exosome Programme
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Bio...
January 07, 2026 | News
Fujifilm Corporation Completes Major Bio CDMO Manufacturing Hub In Japan To Strengthen Asia Biologics Supply
FUJIFILM Corporation announced the completion of one of Japan’s largest bio CDMO facilities (the new plant) at the Toyama Second Factory ...
December 30, 2025 | News
Samsung Biologics Acquires GSK Rockville Facility To Establish First US Manufacturing Site
- Secures the company’s first U.S.-based manufacturing site, strengthening and diversifying its global supply network - Additional investments plann...
December 22, 2025 | News
Esco Aster Provides CMC Manufacturing Support For Shine On Biomedical’s HLA G Targeted Exosome Program
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedica...
December 17, 2025 | News
Thermo Fisher Scientific Advances Microbial Bioprocessing With Chemically Defined Media For Confident Plasmid DNA And Protein Scale Up
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence Thermo Fisher Scientific In...
December 16, 2025 | News
Bora Pharmaceuticals Forms Strategic Alliance with Corealis Pharma to Streamline Drug Development
Partnership creates simplified pathway from early development to commercial launch Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader ...
December 10, 2025 | News
AGC Biologics Strengthens Global Cell Line Capabilities With ATUM Partnership and Leap In Technology
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex mole...
December 04, 2025 | News
BioDlink Drives Global Biologics Innovation with World’s First Approved EGFR-Targeted ADC
Recognized as Biologics CDMO of the Year, BioDlink shares insights into the world's first approved EGFR-targeted ADC for recurrent/metastatic nasopharyng...
December 01, 2025 | News
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
